Search

This article from the Qatar Medical Journal discusses a rare case of acute fibrinous and organizing pneumonia (AFOP) induced by the drug everolimus. The patient, a 54-year-old woman with a history of breast cancer, developed AFOP while taking everolimus. The condition improved after discontinuing the drug and receiving steroid treatment. The article highlights the need for further understanding of the association between everolimus and AFOP, and discusses treatment options for managing the condition. [Extracted from the article]

This article, published in the Qatar Medical Journal, discusses a case of tuberculous pleural effusion (TPE) with profuse mesothelial cell counts. TPE is typically characterized by a predominance of lymphocytes and a scarcity of mesothelial cells, but in this case, the pleural fluid contained a higher percentage of mesothelial cells. The article presents the case of a 33-year-old male who presented with symptoms of TPE and underwent various tests and procedures to confirm the diagnosis. The presence of elevated mesothelial cells in TPE, although rare, should not exclude the consideration of tuberculosis pathology in patients. [Extracted from the article]

The first outbreak of COVID-19 was reported in December 2019 in Wuhan, China and it was declared as a global pandemic on March 11, 2020. To cope with the high infectivity and increasing number of deaths associated with this disease, the healthcare resources of nearly all countries were directed to put measures in place to manage this disease. As a result, many other services including lung cancer care have been adversely affected as treatments have been delayed. The widespread lockdowns and advice to stay at home especially with common symptoms of cough has resulted in late presentations and possible upstaging of lung cancer. Owing to this similarity of symptoms and pressures faced by respiratory community to manage COVID-19 pandemic, the lung cancer patients will encounter delays in their management leading to untoward effects on their survival and quality of lives. According to an estimate, the impact of COVID-19 could lead to an additional 1372 deaths due to lung cancer in the United Kingdom alone. There has also been reluctance among the oncology community to treat patients with systemic anticancer agents due to fear of patients catching COVID-19 infection. There should be a balance between the risks and benefits of providing cancer services during this pandemic and every step should be taken to minimize delays faced by patients with lung cancer. [ABSTRACT FROM AUTHOR]

Objective: To compare the mean time duration of patient's first request for analgesic for pain relief after open cholecystectomy with preoperative use of pregabalin or gabapentin. Study Design: Randomized controlled trial. Place and Duration of Study: Department of anesthesia, Combined Military Hospital (CMH) Peshawar during a period of six months, from May 2014 to Nov 2014. Material and Methods: This study included a total of 126 patients with clinical and ultrasound diagnosis of acute cholecystitis. Patients were distributed randomly into two groups equally (63 patients in each group). Group A was given 300mg pregabalin and group B was given 900mg gabapentin one hour before surgery by mouth. Results: Mean age was 46.68 ± 8.074 years for group A and 46.33 ± 8.046 years for group B. In group A, there were 49.2% males and 50.8% females while in group B, there were 42.9% males and 57.1% females. Weight of patients was 68.54 ± 6.283 kg in group A and 69.75 ± 5.778 kg in group B respectively. Mean time duration score was 37.48 ± 7.175 minutes and 18.27 ± 3.366 minutes in group A and B, respectively (p<0.001). Conclusion: Preoperative use of pregabalin provides significantly prolonged postoperative analgesia compared to gabapentin after open cholecystectomy. [ABSTRACT FROM AUTHOR]

Objective: To observe the efficacy of blind obturator nerve block by Labat technique for prevention of obturator jerk during transurethral resection of bladder tumor performed under spinal anesthesia. Study Design: Descriptive Study. Material and Methods: This was a single center based study conducted at tertiary care military hospital for a period of thirty months. Fifty five patients were recruited in the study, after identifying the location of bladder growth in the lateral wall on ultrasound USG and confirming its exact site on cystoscopic examination. Those eliciting obturator jerk during transurethral resection of bladder tumor (TURBT) were included and ONB was performed using 2% lidocaine via blind technique of Labat. TURBT was restarted and presence of obturator jerk was recorded if evoked (primary outcome). Results: Median age was 67.3 ± 8 years with majority (72.7%) in the age group between 61 to 80 years. Male female ratio was 7:1. Fifty (90%) patients presented with solitary growth. Mean operating time was 28.8 ± 12 minutes. ONB was successful in 52 (94.54%) of the cases while failure in 3 (5.45%) resulted in conversion to general anesthesia for the completion of TURBT. Conclusion: Blind obturator nerve block (ONB) by using Labat technique for obturator nerve block has proven to be simple, reliable and easily replicable in any set up and it does not require any time consuming steps or sophisticated equipment. [ABSTRACT FROM AUTHOR]

Objective: To compare laparoscopic and conventional open appendectomy in terms of operative time, hospital stay and frequency of surgical site infection (SSI). Study Design: Quasi-experimental study. Place and Duration of Study: Combined Military Hospital, Quetta from 6th Jun 2010 to 1st Sep 2011 and Combined Military Hospital, Multan, Pakistan from 2nd Sep 2011 to 5th Jun 2012 over a period of 2 years. Patients and Methods: A total of 417 patients underwent appendectomy during this period. 137 patients underwent laparoscopic appendectomy (group A) while 280 patients had open appendectomy (group B). The sample includes all patients who were operated upon, between the time-span of June 2010 to September 2011. A chi square-test was performed to compare the data for statistical significance. Results: Mean operative time for group A was 79.21 ± 23.42 minutes whereas in group B, the mean operative time was 41.49 ± 20.86 minutes. Group A patients had a shorter hospital, l stay (3.6 ± 1 day) but in group B, it was (5.2 ± 3 days). Seven patients (5.1%) developed surgical site infection (SSI) in group A and 34 patients (12.14%) developed postoperative SSI in group B (p < 0.05). Conclusion: Laparoscopic appendectomy is superior to open appendectomy because of shorter hospital stay and lesser post-operative SSI, but requires longer operative time. [ABSTRACT FROM AUTHOR]

Objectives: Leishmaniasis is quite commonly encountered in Balochistan. Of all the known treatment modalities, only a few are available at our hospital. We carried out this study in search of an effective and easily available agent. Methodology:This quasi-experimental study was carried out at Combined Military Hospital Sibi in Balochistan from May to Nov 2010. The gross appearance of non healing ulcers and demonstration of parasite in Giemsa stained smears were used to confirm the diagnosis. Thirty nine patients were enrolled and divided into two groups by non- probability convenience sampling. Eighteen patients (having 30 ulcers) received meglumine antimoniate and 21 patients (having 32 ulcers) received 0.2% ciprofloxacin intralesionally every fifth day till re-epithelialization started, up to a maximum of five doses. Side effects of therapy were checked at every visit. Patients were followed up at one week and subsequently one month after completion of treatment to assess complete clinical healing and regression in size of the scar. Results:Two ulcers in meglumine antimoniate and five ulcers in ciprofloxacin group did not heal (response rate 93.33% vs. 84.38%, p: 0.273). Those treated with meglumine antimoniate required a lesser number of doses (mean 3.83 and 4.27; p: 0.039). Reduction in scar size was equal in both groups (58.46% and 57.21%; p: 0.087). Conclusions: Intralesional ciprofloxacin is an effective, cheap and safe treatment for cutaneous leishmaniasis. [ABSTRACT FROM AUTHOR]

Competing Interests: There is no conflict of interest in regards to this abstract.

Competing Interests: There is no conflict of interest in regards to this abstract.